会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明授权
    • Compositions and methods for treating and preventing heart tissue degeneration, and uses thereof
    • 用于治疗和预防心脏组织变性的组合物和方法及其用途
    • US08217157B2
    • 2012-07-10
    • US10557873
    • 2004-05-18
    • Hina W. ChaudhryDebra J. Wolgemuth
    • Hina W. ChaudhryDebra J. Wolgemuth
    • C07H21/02C07H21/04A61K48/00
    • A61K38/1703A61K38/12A61K38/1709G01N33/567G01N33/6893G01N2333/4739G01N2800/32
    • The present invention provides methods for promoting generation of heart tissue, and for treating and preventing heart tissue degeneration. Additionally, the present invention provides a therapeutic composition comprising a cyclin-associated agent, and a kit comprising the composition. The present invention further provides a heart tissue cell, a sidepopulation progenitor cell, and a stem cell in which cyclin is augmented. Also provided are cell lines comprising these cells, screening methods using the cell lines, and drugs identified by these methods. The present invention further provides in vitro systems for use in screening candidate drugs for at least one cardiotoxic effect and/or for synergy with cyclin in the treatment and prevention of heart tissue degeneration. Finally, the present invention provides use of a cyclin-associated agent in the generation of heart tissue, and use of a cyclin associated agent in the treatment or prevention of heart tissue degeneration.
    • 本发明提供促进心脏组织产生,以及治疗和预防心脏组织变性的方法。 另外,本发明提供了包含细胞周期蛋白相关药物的治疗组合物和包含该组合物的试剂盒。 本发明还提供了一种心脏组织细胞,侧支祖细胞和其中增殖细胞周期蛋白的干细胞。 还提供了包含这些细胞的细胞系,使用细胞系的筛选方法以及通过这些方法鉴定的药物。 本发明进一步提供用于筛选候选药物至少一种心脏毒性作用的体外系统和/或用于与细胞周期蛋白协同治疗和预防心脏组织变性的体外系统。 最后,本发明提供细胞周期蛋白相关药物在产生心脏组织中的用途,以及细胞周期蛋白相关药物在治疗或预防心脏组织变性中的用途。